DNM2 and cancer: Multiple types of cancer cells have much lower rigidity-sensing ability than their healthy counterparts, due to the lack of contractile units (CUs), including cytoskeletal proteins (Myosin IIA and tropomyosin 2.1 (Tpm 2.1)), and kinases (EGFR, HER2 and ROR2) [395].